VYNE Therapeutics Inc. (VYNE)

VYNE Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	19.93	30.62	30.91	42.25	57.56
Short-Term Investments	41.59	62.63	-	-	1.03
Cash & Short-Term Investments	61.52	93.25	30.91	42.25	58.59
Cash Growth	-34.03%	201.71%	-26.85%	-27.89%	-18.75%
Accounts Receivable	-	-	-	7.58	15.82
Other Receivables	-	-	5	-	-
Receivables	-	-	5	7.58	15.82
Inventory	-	-	-	-	7.4
Prepaid Expenses	2.92	2.66	2.3	4.57	4.59
Restricted Cash	-	0.05	0.07	0.61	0.86
Other Current Assets	-	-	-	8.18	-
Total Current Assets	64.44	95.96	38.28	63.19	87.26
Property, Plant & Equipment	0.21	0.21	-	0.35	2.14
Other Long-Term Assets	2.26	1.52	2.48	3.51	4.35
Total Assets	66.91	97.69	40.76	67.05	93.74
Accounts Payable	2.71	1.66	2.39	6.51	4.78
Accrued Expenses	8.59	3.51	4.26	6.06	10.32
Current Portion of Leases	0.1	0.12	-	0.35	0.76
Current Unearned Revenue	-	-	-	-	5.8
Other Current Liabilities	3.42	2.25	2.7	5.49	0.1
Total Current Liabilities	14.82	7.54	9.35	18.41	21.77
Long-Term Debt	-	-	-	-	33.17
Long-Term Leases	-	0.1	-	-	0.85
Other Long-Term Liabilities	-	1.31	-	-	0.46
Total Liabilities	14.82	8.95	9.35	18.41	56.25
Common Stock	0	0	-	0.01	0
Additional Paid-In Capital	783.24	780.04	693.94	688.16	603.69
Retained Earnings	-731.17	-691.34	-662.74	-639.53	-566.2
Comprehensive Income & Other	0.02	0.03	-	-	-
Total Common Equity	52.09	88.74	31.2	48.64	37.49
Shareholders' Equity	52.09	88.74	31.41	48.64	37.49
Total Liabilities & Equity	66.91	97.69	40.76	67.05	93.74
Total Debt	0.1	0.21	-	0.35	34.78
Net Cash (Debt)	61.42	93.04	30.91	41.9	23.81
Net Cash Growth	-33.99%	201.02%	-26.24%	76.01%	-36.75%
Net Cash Per Share	1.44	9.06	9.70	14.66	13.22
Filing Date Shares Outstanding	15.21	14.1	3.26	3.12	2.85
Total Common Shares Outstanding	14.83	14.1	3.23	2.98	2.4
Working Capital	49.62	88.43	28.93	44.78	65.49
Book Value Per Share	3.51	6.29	9.66	16.34	15.62
Tangible Book Value	52.09	88.74	31.2	48.64	37.49
Tangible Book Value Per Share	3.51	6.29	9.66	16.34	15.62
Machinery	0.12	-	-	0.85	0.94
Leasehold Improvements	-	-	-	0.06	0.06

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q